Cargando…
MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival
MAP17 is a membrane-associated protein that is overexpressed in human tumors. Because the expression of MAP17 increases reactive oxygen species (ROS) generation through SGLT1 in cancer cells, in the present work, we investigated whether MAP17 and/or SGLT1 might be markers for the activity of treatme...
Autores principales: | Perez, Marco, Praena-Fernandez, Juan M., Felipe-Abrio, Blanca, Lopez-Garcia, Maria A., Lucena-Cacace, Antonio, Garcia, Angel, Lleonart, Matilde, Roncador, Guiovanna, Marin, Juan J., Carnero, Amancio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572015/ https://www.ncbi.nlm.nih.gov/pubmed/23418532 http://dx.doi.org/10.1371/journal.pone.0056169 |
Ejemplares similares
-
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
por: Felipe-Abrio, Blanca, et al.
Publicado: (2020) -
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
por: Perez, Marco, et al.
Publicado: (2020) -
c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019) -
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016) -
Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
por: Felipe-Abrio, Blanca, et al.
Publicado: (2019)